Seres Therapeutics
NASDAQ: MCRB
$4.51
as on
Seres Therapeutics Stock Performance
as on August 18, 2026 at 6:59 am IST
Day's Low
Day's High
$4.43$4.58
1.77%
Downside
1.55%
Upside
52 Week's Low
52 Week's High
$4.44$29.981.55%
Downside
564.75%
Upside
Seres Therapeutics share price movements today
- Previous Close
- $4.54
- Open
- $4.50
- Volume
- 196.2K
- Market Cap
- $45.6M
- Day's Low - High
- $4.43 - $4.58
- 52 Week Low - High
- $4.44 - $29.98
Seres Therapeutics Historical Returns
- 1 Month Return
- -14.82 %
- 3 Month Return
- -40.58 %
- 1 Year Return
- -72.8 %
- 3 Year Return
- -93.51 %
- 5 Year Return
- -96.45 %
Seres Therapeutics Stock Fundamentals & Key Indicators
Check Seres Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$45.6M
EPS (TTM)
-2.42
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.92%
PE Ratio (TTM)
-1.85
Industry PE ratio
-1.5966015625
PEG Ratio
0.0006703335100523533
EBITDA
-44.3M
Revenue (TTM)
1.9M
Profit Margin
82.58%
Return On Equity TTM
-60.32%
Seres Therapeutics Stock Valuation
Track how Seres Therapeutics P/E has moved over time to understand its valuation trends.
Seres Therapeutics in the last 5 years
Lowest (-11.65x)
December 31, 2021
Industry (-1.60x)
December 31, 2025
Today (23.25x)
December 31, 2025
Highest (23.25x)
December 31, 2025
Today’s Price to Earnings Ratio: 23.25x
Seres Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Seres Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $45.6M | -96.45% | -1.85 | 82.58% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Seres Therapeutics Stock including INR - Dollar returns
The Seres Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Seres Therapeutics investment value today
Current value as on today
₹29,585
Returns
Returns from Seres Therapeutics Stock
Dollar Impact
₹2,563 (+2.56%)
Analyst Recommendation on Seres Therapeutics Stock
Based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Seres Therapeutics. Average target price of $17
Seres Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Seres Therapeutics.
What analysts predicted
73.47%UPSIDE
Target Price
$17
Current Price
$4.51
Analyzed by
2 Analysts
Target
$17.00
Seres Therapeutics target price $17, a slight upside of 73.47% compared to current price of $4.51. According to 2 analysts rating.
Seres Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Seres Therapeutics Annual Profit & Loss
All numbers in Millions USD
Seres Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Seres Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Seres Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 358.0K → 736.0K (in $), with an average increase of 51.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -19.91M → 4.58M (in $), with an average increase of 534.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 689.0%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 533.7%
NEGATIVE IMPACTPrice Dip
In the last 7 days, MCRB stock has moved down by -9.2%
About Seres Therapeutics
| Organisation | Seres Therapeutics |
| Headquarters | 101 Cambridgepark Drive, Cambridge, MA, United States, 02140 |
| Industry | Biotechnology |
| CEO | Mr. Richard N. Kender B.S., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Seres Therapeutics
Name | Title |
|---|---|
Ms. Kelly Brady M.S. | Executive VP & COO |
Mr. Chris McChalicher | Executive VP & CTO |
Dr. Dennis M. Walling M.D. | Senior VP of Clinical Development & Head of Clinical Research |
Ms. Ann Kurowski | Senior Vice President of Regulatory Affairs |
Mr. Richard N. Kender B.S., M.B.A. | Interim CEO & Executive Chair |
Dr. Matthew R. Henn Ph.D. | President & Chief Scientific Officer |
Ms. Marella Thorell CPA | Executive VP, CFO & Treasurer |
Mr. Thomas J. DesRosier Esq., J.D. | Executive VP, Chief Legal Officer & Secretary |
FAQs
What is Seres Therapeutics share price today?
Seres Therapeutics share price today is $4.51 as on at the close of the market. Seres Therapeutics share today touched a day high of $4.58 and a low of $4.43.
What is the 52 week high and 52 week low for Seres Therapeutics share?
Seres Therapeutics share touched a 52 week high of $29.98 on and a 52 week low of $4.44 on . Seres Therapeutics stock price today i.e. is closed at $4.51,which is 84.96% down from its 52 week high and 1.58% up from its 52 week low.
What is Seres Therapeutics's market capitalisation today?
Seres Therapeutics market capitalisation is $0.00T as on .
How to invest in Seres Therapeutics Stock (MCRB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Seres Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seres Therapeutics Shares that will get you 0.3326 shares as per Seres Therapeutics share price of $4.51 per share as on August 18, 2026 at 1:29 am IST.
What is the minimum amount required to buy Seres Therapeutics Stock (MCRB) from India?
Indian investors can start investing in Seres Therapeutics (MCRB) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Seres Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Seres Therapeutics share’s latest price of $4.51 as on August 18, 2026 at 1:29 am IST, you will get 2.2173 shares of Seres Therapeutics. Learn more about
fractional shares .
What are the returns that Seres Therapeutics has given to Indian investors in the last 5 years?
Seres Therapeutics stock has given -96.45% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?